Cargando…

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia

Treatment paradigm of acute promyelocytic leukemia (APL) is by no mean the most remarkable story of cancer therapy. Recently, the advent of oral arsenic formulations (oral-arsenic trioxide and Realgar-Indigo Naturalis formula (RIF)) based regimens may provide a therapeutic advance by curing APL with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lou, Yinjun, Ma, Yafang, Jin, Jie, Zhu, Honghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892950/ https://www.ncbi.nlm.nih.gov/pubmed/33614484 http://dx.doi.org/10.3389/fonc.2020.597601

Ejemplares similares

Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial
por: Luo, Senlin, et al.
Publicado: (2022)

Clinical Study on Prospective Efficacy of All-Trans Acid, Realgar-Indigo Naturalis Formula Combined with Chemotherapy as Maintenance Treatment of Acute Promyelocytic Leukemia
por: Xiang-Xin, Li, et al.
Publicado: (2014)

Traditional mineral medicine realgar and Realgar-Indigo naturalis formula potentially exerted therapeutic effects by altering the gut microbiota
por: Luo, Lu, et al.
Publicado: (2023)

Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
por: Yang, Ming‐Hua, et al.
Publicado: (2018)

Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
por: Zhang, Xinxin, et al.
Publicado: (2020)

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis
por: Ma, Yafang, et al.
Publicado: (2016)

Influences of Realgar-Indigo naturalis, A Traditional Chinese Medicine Formula, on the Main CYP450 Activities in Rats Using a Cocktail Method
por: Xu, Huan-Hua, et al.
Publicado: (2017)

Absorption Characteristics of Combination Medication of Realgar and Indigo Naturalis: In Vitro Transport across MDCK-MDR1 Cells and In Vivo Pharmacokinetics in Mice after Oral Administration
por: Zhang, Miao, et al.
Publicado: (2018)

Treatment-refractory ulcerative colitis responsive to indigo naturalis
por: Saiki, Julie P, et al.
Publicado: (2021)

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022)

Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease
por: Kim, Hyeon-A, et al.
Publicado: (2019)

Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series
por: Urushikubo, Jun, et al.
Publicado: (2019)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020)

An In Vitro Study of the Antimicrobial Effects of Indigo Naturalis Prepared from Strobilanthes formosanus Moore
por: Chiang, Yin-Ru, et al.
Publicado: (2013)

Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus
por: Tu, Peng, et al.
Publicado: (2020)

Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report
por: Cho, Byungha, et al.
Publicado: (2020)

Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals
por: Wang, Pengyu, et al.
Publicado: (2023)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic
por: Lu, Sheng-ye, et al.
Publicado: (2021)

Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis
por: Cheng, Hui-Man, et al.
Publicado: (2017)

Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community
por: Liang, Yan-Ni, et al.
Publicado: (2019)

Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota
por: Sun, Zhongmei, et al.
Publicado: (2020)

Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis
por: Wang, Yunliang, et al.
Publicado: (2017)

A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis
por: Sun, Quan, et al.
Publicado: (2021)

(-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia
por: Fang, Wei, et al.
Publicado: (2019)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)

From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis
por: Qi-yue, Yang, et al.
Publicado: (2020)

Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification
por: Wu, Xunxun, et al.
Publicado: (2016)

Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha
por: GAO, NA, et al.
Publicado: (2016)

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies
por: LU, JIN, et al.
Publicado: (2014)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2018)

Efficacy and Safety of Indigo Naturalis in Combination with Narrow-Band Ultraviolet B for Treatment of Pityriasis Rosea: A Meta-Analysis
por: Wang, L., et al.
Publicado: (2018)

Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking
por: Gu, Sizhen, et al.
Publicado: (2020)

Indigo Naturalis Suppresses Colonic Oxidative Stress and Th1/Th17 Responses of DSS-Induced Colitis in Mice
por: Xiao, Hai-tao, et al.
Publicado: (2019)

One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
por: Matsuno, Yuichi, et al.
Publicado: (2022)

Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse
por: Gupta, Varsha, et al.
Publicado: (2019)

Corrigendum: Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification
por: Wu, Xunxun, et al.
Publicado: (2016)

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study
por: Zhu, Hong-Hu, et al.
Publicado: (2021)

Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines
por: Ge, Dong-zheng, et al.
Publicado: (2014)

Transcriptional features of acute leukemia with promyelocytic differentiation lacking retinoic acid receptor rearrangements
por: Su, Zhan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gq4lv5aqfr422mknsbvgc0gkjm